TL;DR
This is the first study to demonstrate that IBA and OA exert significant antibiofilm and anti-motility effects against P. aeruginosa NG4 at low concentrations under the conditions tested, providing a foundation for future mechanistic and biological investigations.
MUR exhibits high efficacy against both planktonic and biofilm-forming MDR P. aeruginosa, and its synergy with colistin and tobramycin highlights its potential as a strategic combination partner.
It is suggested that biogenically synthesized MgO NPs hold considerable promise as antibacterial and antibiofilm agents against MDR Gram-negative pathogens.
These findings highlight the biotechnological potential of metabolites from Streptomyces sp.
Findings indicate that N. sativa seed extracts possess antibiofilm potential against P. aeruginosa at subinhibitory concentrations, however, as this was a purely phenotypic study, the mechanisms underlying the observed inhibition remain speculative and require direct experimental investigation.
Findings indicate that multi-halogenated benzophenones act primarily as anti-virulence agents targeting biofilm formation and hyphal development and identify benzophenone scaffolds as promising leads for developing novel antibiofilm strategies against azole-resistant Candida infections.
Evidence is provided that L. rhamnosus can effectively inhibit both biofilm formation and biofilm-associated gene expression in multidrug-resistant P. aeruginosa isolates, highlighting its potential as a promising alternative or adjunctive biocontrol strategy against biofilm-related infections.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
